Use of bisphosphonates in prostate cancer: Current status.
Bisphosphonates are a relatively newer class of drugs which have been used for the prevention of skeletal related complications of age related osteoporosis or metastatic disease from carcinoma breast or multiple myeloma. Their role in the management of prostate cancer is still under evolution. We hereby review the ongoing and some published randomized trials to define the role of bisphosphonates in various stages of prostate cancer.
Nayyar
Rishi
R
Department of Urology, All India Institute of Medical Sciences, New Delhi - 110 029, India.
Gupta
Narmada P
NP
J Urol. 2003 Jun;169(6):2008-12
12771706
BJU Int. 2004 Sep;94(4):524-7
15329105
Cancer. 2004 Mar 1;100(5):892-9
14983482
Br J Cancer. 2001 Apr 20;84(8):1126-34
11308265
Curr Opin Oncol. 2002 Nov;14(6):609-15
12409650
J Urol. 2002 Sep;168(3):1005-7
12187209
Int J Cancer. 1999 Oct 8;83(2):263-9
10471537
BMJ. 2003 Aug 30;327(7413):469
12946966
Clin Orthop Relat Res. 2004 Aug;(425):143-51
15292799
Cancer. 2001 Jun 15;91(12):2238-45
11413511
J Natl Cancer Inst. 2003 Sep 3;95(17):1300-11
12953084
J Urol. 2003 May;169(5):1735-7
12686820
Urol Clin North Am. 2004 May;31(2):313-9
15123410
J Bone Miner Res. 2004 Nov;19(11):1766-70
15476575
Geriatrics. 1999 Sep;54(9):20-2, 27-8, 30 passim
10494225
Cancer. 1997 Feb 1;79(3):545-50
9028366
BJU Int. 2005 May;95(7):935-8
15839907
J Natl Cancer Inst. 2002 Oct 2;94(19):1458-68
12359855
Urol Clin North Am. 2006 May;33(2):191-9, vi
16631457
Osteoporos Int. 1999;9 Suppl 2:S66-80
10525729
Med J Aust. 1997 Oct 20;167(8):412-5
9364155
N Engl J Med. 2001 Sep 27;345(13):948-55
11575286
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30
16514137
J Urol. 2002 Feb;167(2 Pt 1):535-8
11792913
J Clin Oncol. 2003 Dec 1;21(23):4277-84
14581438
N Engl J Med. 2005 Jan 13;352(2):154-64
15647578
J Natl Cancer Inst. 2004 Jun 2;96(11):879-82
15173273
J Clin Oncol. 2003 Sep 1;21(17):3335-42
12947070